Paul D. Callaghan

2.7k total citations
51 papers, 1.8k citations indexed

About

Paul D. Callaghan is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Toxicology. According to data from OpenAlex, Paul D. Callaghan has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 9 papers in Clinical Psychology and 9 papers in Toxicology. Recurrent topics in Paul D. Callaghan's work include Neurotransmitter Receptor Influence on Behavior (15 papers), Neuroscience and Neuropharmacology Research (11 papers) and Forensic Toxicology and Drug Analysis (9 papers). Paul D. Callaghan is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (15 papers), Neuroscience and Neuropharmacology Research (11 papers) and Forensic Toxicology and Drug Analysis (9 papers). Paul D. Callaghan collaborates with scholars based in Australia, United States and United Kingdom. Paul D. Callaghan's co-authors include Iain S. McGregor, Glenn E. Hunt, Murray R. Thompson, Jennifer L. Cornish, Lynette C. Daws, Rodney J. Irvine, Jonathon C. Arnold, Tien Pham, Aurelio Galli and Jonathan A. Javitch and has published in prestigious journals such as Nature Communications, Environmental Science & Technology and PLoS ONE.

In The Last Decade

Paul D. Callaghan

49 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul D. Callaghan Australia	22	824	370	368	332	326	51	1.8k
M. Paola Castelli Italy	35	1.3k 1.5×	838 2.3×	682 1.9×	286 0.9×	213 0.7×	118	3.5k
Romano La Harpe Switzerland	27	947 1.1×	759 2.1×	289 0.8×	246 0.7×	115 0.4×	62	2.1k
Suham Kassir United States	21	948 1.2×	481 1.3×	470 1.3×	352 1.1×	158 0.5×	39	1.9k
Patrick Little United States	22	1.2k 1.5×	400 1.1×	852 2.3×	110 0.3×	92 0.3×	74	2.2k
Christopher M. Olsen United States	21	707 0.9×	509 1.4×	135 0.4×	159 0.5×	93 0.3×	57	1.4k
Donna Walther United States	32	1.5k 1.8×	1.3k 3.5×	403 1.1×	215 0.6×	57 0.2×	73	3.1k
Julie M. Wilson Canada	18	1.0k 1.3×	780 2.1×	155 0.4×	175 0.5×	85 0.3×	57	2.1k
Mickaël Naassïla France	32	1.4k 1.8×	724 2.0×	507 1.4×	280 0.8×	158 0.5×	137	3.1k
Heather M. Haughey United States	18	698 0.8×	297 0.8×	437 1.2×	231 0.7×	45 0.1×	26	1.6k
Jaeuk Hwang South Korea	26	613 0.7×	252 0.7×	191 0.5×	365 1.1×	69 0.2×	73	2.6k

Countries citing papers authored by Paul D. Callaghan

Since Specialization

Citations

This map shows the geographic impact of Paul D. Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Callaghan more than expected).

Fields of papers citing papers by Paul D. Callaghan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Callaghan. The network helps show where Paul D. Callaghan may publish in the future.

Co-authorship network of co-authors of Paul D. Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Callaghan. A scholar is included among the top collaborators of Paul D. Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Callaghan. Paul D. Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lanctôt, Chantal M., Paul D. Callaghan, & Tom Cresswell. (2024). Cadmium bioaccumulation dynamics during amphibian development and metamorphosis. Journal of Hazardous Materials. 474. 134773–134773. 7 indexed citations

Cresswell, Tom, et al.. (2020). Bioaccumulation kinetics and internal distribution of the fission products radiocaesium and radiostrontium in an estuarine crab. Journal of Hazardous Materials. 408. 124453–124453. 10 indexed citations

Krause‐Heuer, Anwen M., Felix P. Mayer, Naomi A. Wyatt, et al.. (2018). Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter. European Journal of Pharmacology. 842. 351–364. 33 indexed citations

Krause‐Heuer, Anwen M., Naomi A. Wyatt, Georgianna G. Gould, et al.. (2017). Evaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22. European Journal of Medicinal Chemistry. 137. 476–487. 9 indexed citations

Brzozowska, Natalia, Kong M. Li, Xiaosuo Wang, et al.. (2017). The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid–Antipsychotic Drug Interactions. Neuropsychopharmacology. 42(11). 2222–2231. 31 indexed citations

Reilhac, Anthonin, et al.. (2015). 4D PET iterative deconvolution with spatiotemporal regularization for quantitative dynamic PET imaging. NeuroImage. 118. 484–493. 13 indexed citations

Callaghan, Paul D., Catriona Wimberley, Paula Berghofer, et al.. (2014). Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18F]PBR102 and [18F]PBR111 in a model of excitotoxin-induced neuroinflammation. European Journal of Nuclear Medicine and Molecular Imaging. 42(1). 138–151. 11 indexed citations

Bennett, Maxwell R., et al.. (2014). Partial genetic deletion of neuregulin 1 and adolescent stress interact to alter NMDA receptor binding in the medial prefrontal cortex. Frontiers in Behavioral Neuroscience. 8. 298–298. 15 indexed citations

Mattner, Filomena, Maria Staykova, Paula Berghofer, et al.. (2013). Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing–Remitting Experimental Autoimmune Encephalomyelitis. Journal of Nuclear Medicine. 54(2). 291–298. 35 indexed citations

10.

Karanges, Emily A., Kong M. Li, Shane M. Wilkinson, et al.. (2012). Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion. PLoS ONE. 7(9). e45473–e45473. 51 indexed citations

11.

Dedeurwaerdere, Stefanie, Paul D. Callaghan, Tien Pham, et al.. (2012). PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. EJNMMI Research. 2(1). 60–60. 74 indexed citations

12.

Katsifis, Andrew, Christian Loc’h, David Henderson, et al.. (2010). A rapid solid-phase extraction method for measurement of non-metabolised peripheral benzodiazepine receptor ligands, [18F]PBR102 and [18F]PBR111, in rat and primate plasma. Nuclear Medicine and Biology. 38(1). 137–148. 14 indexed citations

13.

McGregor, Iain S., Paul D. Callaghan, & Glenn E. Hunt. (2008). From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long‐term adverse consequences of drug use?. British Journal of Pharmacology. 154(2). 358–368. 136 indexed citations

14.

Quinn, Heidi, Izuru Matsumoto, Paul D. Callaghan, et al.. (2007). Adolescent Rats Find Repeated Δ9-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure. Neuropsychopharmacology. 33(5). 1113–1126. 240 indexed citations

15.

Thompson, Murray R., Paul D. Callaghan, Glenn E. Hunt, Jennifer L. Cornish, & Iain S. McGregor. (2007). A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (“ecstasy”). Neuroscience. 146(2). 509–514. 191 indexed citations

16.

Callaghan, Paul D., et al.. (2006). Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine. European Journal of Pharmacology. 546(1-3). 74–81. 6 indexed citations

17.

Callaghan, Paul D., Rodney J. Irvine, & Lynette C. Daws. (2005). Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochemistry International. 47(5). 350–361. 30 indexed citations

18.

Irvine, Rodney J., Michael Keane, Peter Felgate, et al.. (2005). Plasma Drug Concentrations and Physiological Measures in ‘Dance Party’ Participants. Neuropsychopharmacology. 31(2). 424–430. 47 indexed citations

19.

Callaghan, Paul D., Zhaohui Luo, James McKinna, & Robert Pollack. (2002). Types for Proofs and Programs : International Workshop, TYPES 2000, Durham, UK, December 8-12, 2000 : selected papers. Springer eBooks. 2 indexed citations

20.

Daws, Lynette C., et al.. (2000). Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 24(6). 955–977. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact